Medications for Preventing Episodic Migraines

Aimovig, Ajovy, Toprol, and Other Options

Table of Contents
View All
Table of Contents

If you have episodic migraine headache—a subtype of migraine headache disorder defined by the International Classification of Headache Disorders (ICHD-3) as fewer than 15 headache days per month, with or without aura—prevention is key to managing your condition. Avoiding triggers, managing stress, and committing to other healthy lifestyle habits are important, but many with episodic migraines also need to take prophylactic medications—drugs that help prevent migraine attacks.

woman at pharmacy

 People Images / Getty Images

Currently, only one class of drugs that was developed for the sole purpose of preventing migraine headaches is available. All others, so-called oral migraine prevention medications (OMPMs), primarily are used to treat other conditions but have been found useful as migraine prophylactics.

Finding what's most effective for your migraines can take time, and it's important to discuss all the options with your doctor.

Migraine Doctor Discussion Guide

Get our printable guide for your next doctor's appointment to help you ask the right questions.

Doctor Discussion Guide Man

Calcitonin Gene-Related Peptide (CGRP) Antagonists

These prophylactic migraine medications are monoclonal antibodies, a type of biologic drug produced using living systems rather than being synthesized from chemicals. They work by blocking the docking site of a protein called calcitonin gene-related peptide (CGRP) or the CGRP itself, which plays a part in the transmission of pain released from trigeminal nerve fibers that supply sensation to areas of the face.

Four such drugs approved by the Food and Drug Administration (FDA) are Aimovig (erenumab), Ajovy (fremanezumab-vfrm), Vyepti (eptinezumab-jjmr), and Emgality (Galcanezumab-gnlm). In clinical trials, all four have been highly effective for preventing episodic migraine.

In one study, published in late 2017 in the New England Journal of Medicine, patients who took Aimovig had at least 50% fewer headache days after six months of treatment.

Aimovig and Ajovy are injectable medications that you can inject into your thigh or abdomen yourself or have someone else inject into your upper arm. Aimovig comes as either a prefilled syringe or an autoinjector (spring-loaded syringe) to be used once a month. Ajovy is available as a prefilled syringe and is taken as a single injection once a month or three consecutive injections every three months.

Emgality is also taken as a single injection once a month. Vyepti works a little differently. It is administered by a healthcare professional once every three months intravenously (by IV), and the infusion generally takes 30 minutes.

The side effects of this class of drugs are relatively mild, especially compared to those of the OMPMs, and are limited to minimal swelling, redness, or pain at the injection site.


Drugs in this class are primarily used to treat high blood pressure (hypertension). It's thought that these drugs help keep migraine attacks at bay by preventing blood vessels from over-dilating and by calming the nervous system, thus reducing anxiety, according to the National Headache Foundation.

The beta-blockers found most effective for episodic migraine prevention are Toprol (metoprolol), Inderal XL (propranolol), and timolol. They're regarded as level A drugs for this purpose, meaning their effectiveness is proven. Two other beta-blockers, Tenormin (atenolol), and Corgard (nadolol), are level B OMPMs, meaning they're "probably effective."

Beta-blockers may not be a safe choice for people who have asthma, diabetes, symptomatic bradycardia (slow heart rate), or low blood pressure. For others, the drugs can have bothersome side effects including low mood, fatigue, and erectile dysfunction.


Although the physiology of migraine headaches isn't completely understood, scientists believe some of the same structures and functions in the brain that are affected in epilepsy are also involved in migraines.

That's one reason certain medications for managing epileptic seizures are considered level A drugs for preventing migraines—specifically valproic acid (available as Depakote and others) and Topamax (topiramate).

Although they can be effective, these medications have the potential to cause side effects that are bothersome enough to cause people to stop taking them, including weight gain or weight loss, fatigue, dizziness, nausea, changes in taste, tremor, paresthesias, and hair loss.


Amitriptyline is a tricyclic antidepressant that affects mood by blocking the reuptake of the brain chemicals serotonin and norepinephrine. It's this action that may make it an effective prophylactic migraine medication.

However, like other OMPMs, amitriptyline has uncomfortable side effects including nausea and vomiting, dry mouth, constipation, urine retention, weakness, sweating, changes in appetite or weight, and more. It also can cause nightmares and confusion. In addition, the drug can result in cardiovascular problems and shouldn't be taken by people with underlying heart disease.

A Word From Verywell

The toll of a day lost to debilitating pain and other symptoms from episodic migraine, such as nausea and vomiting, can be significant. The development of prophylactic migraine headache medications such as the CGRP antagonists should be a welcome relief for anyone who gets frequent migraines, especially those who have trouble tolerating OMPMs.

There are many options, so if one drug doesn't work for you, talk with your doctor about trying others until you find one that will, at the very least, decrease the number of days you find yourself down for the count with a migraine.

Chronic migraine is characterized by 15 or more headache days per month over the course of three months, with or without aura. If your episodes increase to this extent, be sure to tell your doctor as well.

Was this page helpful?
Article Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Goadsby PJ, Reuter U, Hallström Y, et al. A controlled trial of erenumab for episodic migraineN Engl J Med. 2017 Nov;377(22):2123-2132. doi:10.1056/NEJMoa1705848

  2. National Headache Foundation. Beta-blockers.

  3. Shahien R, Beiruti K. Preventive agents for migraine: Focus on the antiepileptic drugsJournal of Central Nervous System Disease. 2012 Jan;4(1):37-49. doi:10.4137/JCNSD.S9049

Additional Reading